Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep4-2026a10006hl. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Psoriasis https://emedicine.medscape.com/article/1943419-overview

Lyme Disease https://emedicine.medscape.com/article/330178-overview

Synovial Fluid Eosinophilia in Lyme Disease https://pubmed.ncbi.nlm.nih.gov/3056421/

Rheumatoid Arthritis (RA) Treatment & Management https://emedicine.medscape.com/article/331715-treatment

Psoriatic Arthritis Treatment & Management https://emedicine.medscape.com/article/2196539-treatment#d9

A Review of Biosimilars for Rheumatoid Arthritis https://pubmed.ncbi.nlm.nih.gov/35552095/

Drift, Evolution, and Divergence in Biologics and Biosimilars https://pubmed.ncbi.nlm.nih.gov/24567263/

FDA Updates Guidance on Interchangeability https://www.fda.gov/drugs/drug-alerts-and-statements/fda-updates-guidance-interchangeability

Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention https://pubmed.ncbi.nlm.nih.gov/32205569/

Physicochemical and Biological Similarity Assessment of LBAL, a Biosimilar to Adalimumab Reference Product (Humira®) https://pubmed.ncbi.nlm.nih.gov/34262661/

GP2017, an Adalimumab Biosimilar: Pharmacokinetic Similarity to Its Reference Medicine and Pharmacokinetics Comparison of Different Administration Methods https://pubmed.ncbi.nlm.nih.gov/30698045/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep3-2026a10006hk. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Psoriasis https://emedicine.medscape.com/article/1943419-overview

Psoriasis: An Update on Topical and Systemic Therapies https://pubmed.ncbi.nlm.nih.gov/40568686/

Crosstalk Between White Adipose Tissue and Skin: Unraveling Its Role in Psoriasis Pathogenesis (Review) https://pubmed.ncbi.nlm.nih.gov/40242953/

Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis With Biologics https://pubmed.ncbi.nlm.nih.gov/30772098/

Joint American Academy of Dermatology-National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologic Therapies https://pubmed.ncbi.nlm.nih.gov/32119894/

Oral Janus Kinase Inhibitors in the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis https://pubmed.ncbi.nlm.nih.gov/36751339/

Janus Kinase Inhibitors for Alopecia Areata: A Review of Clinical Data https://pubmed.ncbi.nlm.nih.gov/40433365/

Herpes Zoster https://emedicine.medscape.com/article/1132465-overview

Clinical Testing Guidance for Tuberculosis: Interferon Gamma Release Assay https://www.cdc.gov/tb/hcp/testing-diagnosis/interferon-gamma-release-assay.html

Utility of Repeat Latent Tuberculosis Testing With the QuantiFERON-TB Gold Test in Patients With Psoriasis Treated With Tumour Necrosis Factor-α Inhibitors at a Single U.S. Institution https://pubmed.ncbi.nlm.nih.gov/31452192/

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Drs Steven Feldman and Tina Bhutani-Jacques explore how next-generation oral therapies are closing the gap with biologics and reshaping psoriasis care.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Acitretin Revisited in the Era of Biologics https://pubmed.ncbi.nlm.nih.gov/20673152/

Apremilast in Psoriasis: Current Landscape and Perspectives https://pubmed.ncbi.nlm.nih.gov/40739686/

Deucravacitinib Versus Placebo and Apremilast in Moderate-to-Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial https://pubmed.ncbi.nlm.nih.gov/35820547/

Apremilast Prescribing Information https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf

Deucravacitinib Prescribing Information https://packageinserts.bms.com/pi/pi_sotyktu.pdf

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39167366/

Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/

National Psoriasis Foundation https://www.psoriasis.org/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.